Research Topics
Species | Julie K HeimbachSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease disseminationJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
HPB (Oxford) 13:356-60. 2011..The aim of the present study was to determine whether patients who have undergone transperitoneal FNA of the primary tumour have a higher incidence of metastases...
Successful liver transplantation for hilar cholangiocarcinomaJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Curr Opin Gastroenterol 24:384-8. 2008..The purpose of this review is to present recent data demonstrating the success of neoadjuvant therapy followed by liver transplantation for hilar cholangiocarcinoma...- Liver transplantation for hepatocellular carcinomaJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Cancer J 14:95-9. 2008..In addition, the role of certain immunosuppressive agents such as sirolimus in the reducing HCC recurrence posttransplant remains unclear... 
Living donor liver transplantation using a right lobe graft in an adult with situs inversusJulie K Heimbach
Division of Transplantation Surgery, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA
Liver Transpl 11:111-3. 2005..This is the first report of a successful living donor right liver graft in an adult with end-stage liver disease secondary to primary sclerosing cholangitis and situs inversus totalis...- Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinomaJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Transplantation 82:1703-7. 2006..We reviewed our experience with the aim to identify clinicopathological predictors of disease recurrence... - Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvant therapy: a new paradigm for liver and biliary malignancies?Julie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Surgery 140:331-4. 2006 - Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinomaHendrik T J Mantel
William J von Liebig Transplant Center, Department of Radiology, Mayo Clinic Rochester and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Liver Transpl 13:1372-81. 2007..Liver transplantation with neoadjuvant therapy is associated with far higher rates of late arterial and portal venous complications, but these complications do not adversely affect patient and graft survival... - Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients DatabaseKymberly D Watt
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation Rochester, MN 55905, USA
Liver Transpl 18:1029-36. 2012..This study confirms the association of tacrolimus with superior outcomes. Sirolimus should be used sparingly in recipients with HCV infections... - Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinomaDavid J Rea
Division of Gstroenterologic and General Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
Ann Surg 242:451-8; discussion 458-61. 2005.... - The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variablesAndres Duarte-Rojo
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
Transplantation 94:197-203. 2012..Its role on disease biology and progression is less clear. We characterized the effects of IL28B genotype on HCV recurrence, allograft histology, rate of SVR, and survival after liver transplantation (LT) in HCV... - Transplantation for hilar cholangiocarcinomaJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, MN, USA
Liver Transpl 10:S65-8. 2004..4. Survival following liver transplantation for unresectable, perihilar CCAs, mass lesion if present <3 cm, is greater than 80% at 5 years. 5. Patients with intrahepatic CCAs are not eligible for liver transplantation... - Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomyJulie K Heimbach
Mayo Clinic College of Medicine, Department of Transplant Surgery, Rochester, Minnesota, USA
Am J Transplant 5:1057-64. 2005..While early results are encouraging, we advocate careful study of obese donors and do not support their widespread use until longer follow-up is available... - Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary?Charles B Rosen
Division of Transplantation Surgery, Mayo Clinic Rochester and Mayo Clinic College of Medicine, Rochester, MN 55905, USA
J Am Coll Surg 215:31-8; discussion 38-40. 2012..Pathologic confirmation of CCA is notoriously difficult, and many patients have been treated based on clinical criteria without pathological confirmation... - Liver transplantation for unresectable perihilar cholangiocarcinomaJulie K Heimbach
William J von Liebig Transplant Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Semin Liver Dis 24:201-7. 2004..Neoadjuvant chemoradiotherapy with liver transplantation achieves excellent results for patients with localized, regional lymph node negative, hilar cholangiocarcinoma... - Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levelsElizabeth Coss
Mayo Clinic Transplant Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Liver Transpl 17:23-31. 2011..In conclusion, pretransplant elevated troponin levels, diabetes, and a history of cardiovascular disease, alone or in combination, are strongly associated with the occurrence of posttransplant cardiovascular events... - Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United StatesMichael R Charlton
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
Gastroenterology 141:1249-53. 2011..The relative frequency of nonalcoholic steatohepatitis (NASH) as an indication for liver transplantation and comparative outcomes following transplantation are poorly understood... - Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinomaSarwa Darwish Murad
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 56:972-81. 2012..Recurrence risk is mostly associated with presence of residual cancer on explant. Patients with PSC do not have an independent survival advantage over de novo patients, but present with more favorable tumor characteristics... - Liver transplantation for cholangiocarcinomaCharles B Rosen
Division of Transplantation Surgery, Mayo Clinic, Rochester, MN 55905, USA
Transpl Int 23:692-7. 2010.... - Long-term probability of and mortality from de novo malignancy after liver transplantationKymberly D S Watt
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Gastroenterology 137:2010-7. 2009..We analyzed a multicenter, prospectively obtained database to assess the probabilities of and risk factors for de novo malignancies in patients after liver transplantation... - Transplantation for cholangiocarcinoma: when and for whom?David J Rea
Division of Transplantation Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Surg Oncol Clin N Am 18:325-37, ix. 2009..This approach has achieved results superior to standard surgical therapy, with 72% 5-year survival for patients with unresectable disease... - Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFRLourdes S Peña de la Vega
Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Kidney Int 66:1654-61. 2004..Donor age adversely affects deceased-donor kidney transplant outcomes, but its influence on living-donor transplantation is less well characterized... - Endoscopic ultrasound staging of cholangiocarcinomaMichael J Levy
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
Curr Opin Gastroenterol 28:244-52. 2012..In this review we examine the utility of endoscopic ultrasound (EUS), which is increasingly used in this setting to overcome the limitations of other imaging and biopsy techniques... - Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantationKymberly D S Watt
Mayo Clinic Transplant Center, Rochester, MN 55905, USA
Liver Transpl 16:990-8. 2010..In summary, elevated pretransplant serum TN levels are strongly predictive of mortality and graft loss after liver transplantation and may be helpful in risk stratification of potential liver transplant recipients... - Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipientsMichael B Ishitani
William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
Am J Transplant 5:1689-93. 2005..These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality... - Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantationStepan Sembera
William J von Leibig Transplant Center, Mayo Clinic, Rochester, MN 55905, USA
Liver Transpl 18:803-10. 2012..In conclusion, DILI is a rare yet underrecognized event among LT recipients. The majority of cases are not clinically severe, and they resolve after drug cessation without hepatic retransplantation or death... - Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centersSarwa Darwish Murad
William J von Liebig Transplant Center, Mayo Clinic, Rochester, Minnesota 55905, USA
Gastroenterology 143:88-98.e3; quiz e14. 2012..We analyzed data from multiple centers to determine the effectiveness of this treatment and the appropriateness of the MELD exception... - Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteinsAsem H Ali
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota, USA
Diabetes 60:2300-7. 2011..Because direct adipose tissue free fatty acid (FFA) storage may contribute to body fat distribution, we measured FFA (palmitate) storage rates and fatty acid (FA) storage enzymes/proteins in omental and abdominal subcutaneous fat... - Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infectionMichael R Charlton
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Hepatology 53:317-24. 2011..The data suggest that CC donor livers might be preferentially allocated to patients with HCV infection... - APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort studyMark T Keegan
Division of Critical Care, Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
BMC Surg 9:11. 2009..The area under the receiver operating characteristic curve (AUC) and the Hosmer-Lemeshow C statistic were used to assess, respectively, discrimination and calibration of APACHE III... - Hand-assisted laparoscopic donor nephrectomy for pediatric kidney allograft recipientsDean Y Kim
Department of Surgery, Division of Transplantation Surgery, William J. von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, 200 First Street SW, Rochester, MN 55905, USA
Pediatr Transplant 8:460-3. 2004..In conclusion, hand-assisted LDN is a safe method of procuring kidneys from potential donors with no significant negative outcomes to the pediatric recipients... - Changes in transfusion practice over time in adult patients undergoing liver transplantationJames Y Findlay
Department of Anesthesiology and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Cardiothorac Vasc Anesth 27:41-5. 2013..The aim of this study was to investigate changes in transfusion practice over time in liver transplantation surgery and to evaluate potential causes for changes in practice and report associated perioperative morbidity and mortality... - Predicting failure of outpatient laparoscopic cholecystectomyThomas N Robinson
Department of Surgery, Denver Health Medical Center/University of Colorado Health Sciences Center, USA
Am J Surg 184:515-8; discussion 518-9. 2002..CONCLUSIONS: Outpatient LC is feasible in a large county hospital. These data may be used in scheduling cases and counseling patients...